Volume 130, Issue 6, Pages (December 2006)

Slides:

Advertisements

Similar presentations

Volume 32, Issue 1, Pages (July 1957)

Advertisements

Volume 34, Issue 2, Pages (August 1958)

Tell-tale Telangiectasias

Volume 149, Issue 5, Pages (May 2016)

Colloquium on Therapy of Right Heart Failure

Volume 149, Issue 6, Pages (June 2016)

Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke

When to Be Rash About a Fever and Headache

Right-Sided Chest Pain with Progressive Dyspnea

Volume 144, Issue 4, Pages (October 2013)

Epidemiology and Treatment of Lung Cancer in Seattle

Bovine Tuberculosis Eradication

Volume 133, Issue 4, Pages (April 2008)

Volume 121, Issue 3, Pages (March 2002)

Wan-Jie Gu, MSc, Chun-Yin Wei, MSc, Rui-Xing Yin, MD, PhD CHEST

Robert Pickering, M.D, Fernando J. Martinez, M.D CHEST

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Volume 102, Issue 6, Pages (December 1992)

Ann Intern Med. 2009;150(11): doi: / Figure Legend:

Air Pollution and Chest Disease

Navin K. Jain, MD, Thiam H. Lie, MD, FCCP CHEST

Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia

Volume 139, Issue 5, Pages (May 2011)

Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer Russell D. Hull, MBBS, MSc, Graham F. Pineo,

Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F

Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD CHEST

Volume 143, Issue 1, Pages (January 2013)

Prevention of VTE in Orthopedic Surgery Patients

Volume 137, Issue 2, Pages (February 2010)

Paul D. Stein, MD, Russell D. Hull, MBBS, MSc, Fadi Matta, MD, Abdo Y

Ketamine as Rescue Treatment for Difficult-to-Sedate Severe Acute Behavioral Disturbance in the Emergency Department Geoffrey Kennedy Isbister, MD, FACEM,

Amandeep Singh, MD, Harrison J. Alter, MS, MD, Amy Littlepage, MD

Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: A meta-analysis Peter Donndorf, MD, Guenther Kundt, PhD,

Russell D. Hull, MBBS, MSc, Jane Liang, MSc, Grace Townshend, MSc

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation Giulia Renda, MD, PhD, Marco.

Volume 150, Issue 6, Pages (December 2016)

Prevention of VTE in Orthopedic Surgery Patients

New oral anticoagulants—what the cardiothoracic surgeon needs to know

Probiotics for Prevention of Ventilator-Associated Pneumonia: Response

Succinct Review of the New VTE Prevention and Management Guidelines

Has the 6-Min Walk Distance Run Its Course?

EGFR Molecular Profiling in Advanced NSCLC: A Prospective Phase II Study in Molecularly/Clinically Selected Patients Pretreated with Chemotherapy Michele.

Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer Russell D. Hull, MBBS, MSc, Graham F. Pineo,

Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F

Antithrombotic Therapy for VTE Disease

Counterpoint: Should All ICU Patients Receive Continuous Sedation? No

Outpatient Pulmonary Embolism Management: If You Walk Into the Emergency Department With a Pulmonary Embolism, Maybe You Should Also Walk Out Tyler W.

Treatment Options for Pediatric Patent Ductus Arteriosus

Abscess Incision and Drainage With or Without Ultrasonography: A Randomized Controlled Trial Romolo J. Gaspari, MD, PhD, Alexandra Sanseverino, MD, Timothy.

Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1

Imaging for the Management of Community-Acquired Pneumonia

How I treat cancer-associated venous thromboembolism

Direct Oral Anticoagulants vs Low-Molecular–Weight Heparin for Thromboprophylaxis in Nonoperative Pelvic Fractures Mohammad Hamidi, MD, Muhammad Zeeshan,

Treatment and secondary prevention strategy diagram for VTE in patients with active cancer based on the treatment guidelines for cancer-associated VTE.

Incidence of (A) recurrent VTE and (B) major bleeding in select randomised clinical trials of LMWH for the treatment and secondary prevention of VTE in.

Volume 135, Issue 2, Pages (February 2009)

S. Seshadri, S.K. Sunkara, Y. Khalaf, T. El-Toukhy, H. Hamoda

Volume 92, Issue 1, Pages (July 1987)

Bedside Calibration Of Pulmonary Artery Catheters

Invasive Pulmonary Aspergillosis

Do CIs Give You Confidence?

Interaction of Rifampin and Glyburide

Volume 42, Issue 2, Pages (August 1962)

Volume 150, Issue 4, Pages (October 2016)

Thoracic Surgery Survey on Lung Cancer Management

POINT: Should Inhaled Antibiotic Therapy Be Used Routinely for the Treatment of Bacterial Lower Respiratory Tract Infections in the ICU Setting? Yes

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation Giulia Renda, MD, PhD, Marco.

New Members of the Editorial Board

John Reid, MD, Donald Cockcroft, MD CHEST

Treatment algorithm. Treatment algorithm. (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE in cancer patients. (B) Suggested.

Presentation transcript:

Volume 130, Issue 6, Pages 1808-1816 (December 2006) Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular- Weight Heparin Compared With Oral Anticoagulants? Ferretti Gianluigi , MD, PhD, Bria Emilio , MD, Giannarelli Diana , MD, PhD, Carlini Paolo , MD, Felici Alessandra , MD, Mandalà Mario , MD, Papaldo Paola , MD, Fabi Alessandra , MD, Ciccarese Mariangela , MD, Cuppone Federica , MD, Cecere Fabiana Letizia , MD, Nuzzo Carmen , MD, Terzoli Edmondo , MD, Cognetti Francesco , MD CHEST Volume 130, Issue 6, Pages 1808-1816 (December 2006) DOI: 10.1378/chest.130.6.1808 Copyright © 2006 The American College of Chest Physicians Terms and Conditions

Figure 1 Flow diagram. RCTs = randomized controlled trials. CHEST 2006 130, 1808-1816DOI: (10.1378/chest.130.6.1808) Copyright © 2006 The American College of Chest Physicians Terms and Conditions

Figure 2 VTE during follow-up after active anticoagulant treatment. Effect = RR; Lower = 95% CI RR lower limit; Upper = 95% CI RR upper limit; Ntotal = total number of patients; Fixed Combined = fixed-effect model estimation; Random Combined = random-effect model estimation. OA = oral anticoagulants. Treated = patients receiving LMWH; Control = patients receiving oral antagonists. CHEST 2006 130, 1808-1816DOI: (10.1378/chest.130.6.1808) Copyright © 2006 The American College of Chest Physicians Terms and Conditions

Figure 3 VTE during active anticoagulant treatment. See Figure 2 for explanation of terms. CHEST 2006 130, 1808-1816DOI: (10.1378/chest.130.6.1808) Copyright © 2006 The American College of Chest Physicians Terms and Conditions

Figure 4 VTE during active anticoagulant treatment in cancer patients. See Figure 2 for explanation of terms. CHEST 2006 130, 1808-1816DOI: (10.1378/chest.130.6.1808) Copyright © 2006 The American College of Chest Physicians Terms and Conditions

Figure 5 Funnel plot of SE by effect size concerning those studies8,1011,1213,14,15 selected for assessing recurrent VTE during follow-up after cessation of active treatment. CHEST 2006 130, 1808-1816DOI: (10.1378/chest.130.6.1808) Copyright © 2006 The American College of Chest Physicians Terms and Conditions